AMARIN CORP PLC\UK (AMRN)
New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2026
New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2026
📈 **POSITIVE** • Low confidence analysis (51%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (76%) **Content type:** Clinical